This latest software enhancement to DexCom G4 Platinum will make the performance level of blood glucose monitoring comparable to finger stick meters, the traditional standard-of-care for the same.

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc., (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today that the U.S. Food and Drug Administration (FDA) has approved new software for ...

A Dexcom (NSDQ:DXCM) communication on its website states that it will soon cease manufacturing for its G6 continuous glucose ...

The FDA has approved updat- ed, more accurate software for the Dexcom G4 Platinum pediatric continuous glucose monitoring (CGM) system. The approval, granted May 22, 2015, reflects soft-ware changes ...

(COLORADO SPRINGS) — A medical device for diabetes called the Dexcom is facing a national shortage that’s now leaving diabetics in Southern Colorado frustrated. A Dexcom is responsible for monitoring ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose ...

Diabetes tracker developer Dexcom is pushing back the timeline for a U.S. launch of the latest generation of its continuous glucose monitor, the G7, after the FDA raised questions about the device’s ...

Dexcom, the company behind one of the leading continuous glucose monitor solutions for diabetes patients, has announced today that their “Follow” mobile app—which has long been available on iOS—is now ...

(Corrects to identify the issue is with the Dexcom Follow monitoring service, not the monitor itself) NEW YORK, Dec 1 (Reuters) - Dexcom Inc, which makes continuous glucose monitoring systems that can ...

DexCom, Inc. ( DXCM) recently revealed the U.S. Food and Drug Administration (FDA) approval for a new algorithm designed for its G4 PLATINUM Continuous Glucose Monitoring (CGM) system. Following the ...